featured
Individualized ACE-Inhibitor Therapy in Patients With Stable CAD Based on Clinical and Pharmacogenetic Determinants
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Heart Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model
J Am Heart Assoc 2016 Apr 01;5(3)e002688, RM Oemrawsingh, KM Akkerhuis, LC Van Vark, WK Redekop, G Rudez, WJ Remme, ME Bertrand, KM Fox, R Ferrari, AH Danser, M de Maat, ML Simoons, JJ Brugts, E BoersmaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.